Skip to main content
. 2021 Dec 8;45(2):348–356. doi: 10.2337/dc21-1692

Table 1.

Baseline characteristics of participants from the NHS II by history of GDM

No history of GDM (n = 51,174; 94.7%) History of GDM (n = 2,888; 5.3%)
Mean (SD) age, years 43.4 (3.9) 43.2 (3.8)
Mean (SD) weight, kg 69.6 (15.9) 75.1 (19.3)
Mean (SD) BMI, kg/m2 25.6 (5.6) 27.9 (6.8)
White 50,272 (98.2) 2,824 (97.8)
Married 49,682 (97.1) 2,752 (95.3)
Family history of diabetes 18,107 (35.4) 1,482 (51.3)
Parity
 0 243 (0.5) 17 (0.6)
 1 8,771 (17.1) 393 (13.6)
 2 24,924 (48.7) 1,308 (45.3)
 3 12,796 (25.0) 810 (28.0)
 4+ 4,440 (8.7) 360 (12.5)
Oral contraceptive use
 Current user 3,113 (6.1) 151 (5.2)
 Past user 41,632 (81.4) 2,338 (81.0)
 Never user 6,429 (12.6) 399 (13.8)
Combined menopausal and HRT use status
 Premenopausal never HRT user 44,556 (87.1) 2,538 (87.9)
 Postmenopausal never HRT user 829 (1.6) 41 (1.4)
 Postmenopausal current HRT user 1,347 (2.6) 90 (3.1)
 Postmenopausal past HRT user 2,898 (5.7) 128 (4.4)
 Missing 1,544 (3.0) 91 (3.2)
Total daily sleep, h
 ≤6 13,699 (28.5) 819 (29.9)
 7–8 31,979 (66.5) 1,770 (64.7)
 >8 2,408 (5.0) 149 (5.4)
Mean (SD) total energy intake, kcal 1,809 (549) 1876 (573)
Mean (SD) AHEI score 51.2 (11.9) 51.2 (11.8)
Median physical activity (IQR), MET-h/week§ 13.1 (5.7, 25.9) 11.3 (4.9, 22.2)
Mean (SD) alcohol use, servings/day 0.3 (0.6) 0.2 (0.5)
Smoking status
 Never 33,875 (66.2) 1,951 (67.6)
 Past 12,693 (24.8) 700 (24.2)
 Current 4,606 (9.0) 237 (8.2)

Data are n (%) unless stated otherwise. Baseline was defined as first follow-up cycle when a woman reached age 40 years.

HRT, hormone replacement therapy; IQR, interquartile range.

History of ever reporting a pregnancy complicated by GDM.

Duration of sleep was assessed in 2001 and 2009 questionnaires only. Numbers are presented based on sleep data collected in the 2001 questionnaires.

§

Metabolic equivalents from leisure-time physical activities of moderate or vigorous intensity were summed.